StudyRareStudyRare

Tangier disease

Log in to star

Last updated Nov 4, 2026

Log in to add personal notes on this page.

A child has strikingly enlarged, yellow-orange tonsils. A fasting lipid panel shows HDL cholesterol near zero and a markedly reduced apolipoprotein A-I. He also has mild hepatosplenomegaly and patchy sensory loss consistent with peripheral neuropathy.

AR; ABCA1 (ATP-binding cassette transporter A1, the membrane flippase that loads cholesterol onto apoA-I). Loss-of-function variants, including missense variants that disrupt apoA-I or ATP binding or membrane trafficking, and rare large deletions.

ABCA1 is the pump that exports free cholesterol and phospholipids out of cells onto lipid-poor apolipoprotein A-I, the first step in building nascent HDL. Without a working pump:

  1. ApoA-I reaches the cell surface but has nothing to load onto, so it is degraded within hours instead of maturing into HDL. HDL-C and apoA-I both fall toward zero.
  2. The cholesterol that should have left the cell stays inside, and macrophages throughout the reticuloendothelial system (tonsils, spleen, liver, bone marrow, peripheral nerves, cornea) swell with cholesteryl esters.
  3. The familial hypercholesterolemia intuition, low HDL means high cardiovascular risk, only partly applies here: LDL is also low in Tangier disease, so atherosclerosis is accelerated but more modest than the HDL number alone would predict.
membrane lipid flippaseABCA1; loads them onto apoA-ITangier diseasecholesterol andphospholipid in cellsnascent HDL
Excerpt from cholesterol synthesis and transport. See the full pathway.

Part of cholesterol synthesis and transport.

HDL formation, the cholesterol efflux step that loads apolipoprotein A-I.

free cholesterol and phospholipid inside cells → ABCA1 (the block; membrane lipid flippase) → loaded onto apoA-I → nascent HDL → circulating HDL

  • Accumulates: cholesteryl esters in reticuloendothelial cells (tonsils, lymph nodes, spleen, liver, intestinal mucosa), with mild to moderate hypertriglyceridemia from excess VLDL.
  • Missing: HDL cholesterol and apoA-I, because lipid-poor apoA-I particles are degraded in the kidney.
  • Hyperplastic, yellow-orange tonsils (the classic finding)
  • HDL-C near zero, apoA-I markedly reduced
  • Hepatosplenomegaly
  • Peripheral neuropathy (relapsing-remitting or chronic progressive)
  • Corneal opacities, usually without visual impairment
  • Premature coronary artery disease, typically 6th-7th decade
  • Fasting lipid panel: HDL-C near zero, low apoA-I, mild hypertriglyceridemia
  • Confirm with biallelic pathogenic ABCA1 variants
  • Enlarged orange tonsils plus near-absent HDL is close to pathognomonic; don't mistake the tonsil finding for chronic tonsillitis
  • Supportive; no therapy restores ABCA1 function
  • Standard cardiovascular risk-factor management
  • Monitor for progression of peripheral neuropathy

"Tangier = tangerine tonsils" 🍊: hyperplastic, yellow-orange tonsils are the most recognizable finding, the color comes from cholesteryl-ester-engorged macrophages packed into the tonsil, not a pigment problem.

"No efflux, no HDL": ABCA1 is the efflux pump that loads cholesterol onto apoA-I to build HDL. No pump means apoA-I is degraded before HDL ever forms (HDL crashes to near zero) while the cholesterol it should have carried away backs up inside macrophages, the same lipid-laden macrophages that turn the tonsils orange.